6MA Stock Overview
Ambea AB (publ) provides housing, support, education, and personnel for health and social care for the elderly and people with disabilities in Sweden, Norway, and Denmark.
Price History & Performance
|Historical stock prices|
|Current Share Price||kr4.83|
|52 Week High||kr7.93|
|52 Week Low||kr3.96|
|1 Month Change||10.27%|
|3 Month Change||1.68%|
|1 Year Change||-37.08%|
|3 Year Change||-31.27%|
|5 Year Change||n/a|
|Change since IPO||-40.62%|
Recent News & Updates
|6MA||DE Healthcare||DE Market|
Return vs Industry: 6MA underperformed the German Healthcare industry which returned -9.8% over the past year.
Return vs Market: 6MA underperformed the German Market which returned -10.6% over the past year.
|6MA Average Weekly Movement||5.8%|
|Healthcare Industry Average Movement||5.3%|
|Market Average Movement||6.3%|
|10% most volatile stocks in DE Market||10.2%|
|10% least volatile stocks in DE Market||3.4%|
Stable Share Price: 6MA is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 6MA's weekly volatility (6%) has been stable over the past year.
About the Company
Ambea AB (publ) provides housing, support, education, and personnel for health and social care for the elderly and people with disabilities in Sweden, Norway, and Denmark. The company operates through Nytida, Vardaga, Stendi, Altiden, and Klara segments. The Nytida segment comprises residential facilities, support for individuals and families, schools for children, young people and adults with disabilities or psychosocial problems, and day services.
Ambea Fundamentals Summary
|6MA fundamental statistics|
Is 6MA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|6MA income statement (TTM)|
|Cost of Revenue||kr8.62b|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
May 04, 2022
|Earnings per share (EPS)||2.51|
|Net Profit Margin||2.06%|
How did 6MA perform over the long term?See historical performance and comparison
2.3%Current Dividend Yield
Does 6MA pay a reliable dividends?See 6MA dividend history and benchmarks
|Ambea dividend dates|
|Ex Dividend Date||May 13 2022|
|Dividend Pay Date||May 19 2022|
|Days until Ex dividend||17 days|
|Days until Dividend pay date||23 days|
Does 6MA pay a reliable dividends?See 6MA dividend history and benchmarks
Is Ambea undervalued compared to its fair value and its price relative to the market?
Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 6MA (€4.83) is trading below our estimate of fair value (€16.72)
Significantly Below Fair Value: 6MA is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 6MA is good value based on its PE Ratio (20.2x) compared to the German Healthcare industry average (21.5x).
PE vs Market: 6MA is poor value based on its PE Ratio (20.2x) compared to the German market (18.8x).
Price to Earnings Growth Ratio
PEG Ratio: 6MA is good value based on its PEG Ratio (0.8x)
Price to Book Ratio
PB vs Industry: 6MA is good value based on its PB Ratio (1.1x) compared to the DE Healthcare industry average (1.5x).
How is Ambea forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Future Growth Score3/6
Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 6MA's forecast earnings growth (25.3% per year) is above the savings rate (-0.05%).
Earnings vs Market: 6MA's earnings (25.3% per year) are forecast to grow faster than the German market (8.6% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 6MA's revenue (4.2% per year) is forecast to grow slower than the German market (5.3% per year).
High Growth Revenue: 6MA's revenue (4.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 6MA's Return on Equity is forecast to be low in 3 years time (12.3%).
How has Ambea performed over the past 5 years?
Past Performance Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 6MA has a large one-off loss of SEK108.0M impacting its December 31 2021 financial results.
Growing Profit Margin: 6MA's current net profit margins (2.1%) are lower than last year (3.2%).
Past Earnings Growth Analysis
Earnings Trend: 6MA's earnings have grown by 13.1% per year over the past 5 years.
Accelerating Growth: 6MA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 6MA had negative earnings growth (-34%) over the past year, making it difficult to compare to the Healthcare industry average (34%).
Return on Equity
High ROE: 6MA's Return on Equity (5.2%) is considered low.
How is Ambea's financial position?
Financial Health Score2/6
Financial Health Score 2/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 6MA's short term assets (SEK1.8B) do not cover its short term liabilities (SEK4.3B).
Long Term Liabilities: 6MA's short term assets (SEK1.8B) do not cover its long term liabilities (SEK7.8B).
Debt to Equity History and Analysis
Debt Level: 6MA's net debt to equity ratio (56.2%) is considered high.
Reducing Debt: 6MA's debt to equity ratio has reduced from 109.2% to 58.1% over the past 5 years.
Debt Coverage: 6MA's debt is well covered by operating cash flow (45.9%).
Interest Coverage: 6MA's interest payments on its debt are not well covered by EBIT (2.7x coverage).
What is Ambea current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Future Dividend Coverage
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: 6MA's dividend (2.27%) is higher than the bottom 25% of dividend payers in the German market (1.28%).
High Dividend: 6MA's dividend (2.27%) is low compared to the top 25% of dividend payers in the German market (3.88%).
Stability and Growth of Payments
Stable Dividend: 6MA has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 6MA's dividend payments have increased, but the company has only paid a dividend for 4 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (45.9%), 6MA's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (9.8%), 6MA's dividend payments are thoroughly covered by cash flows.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mark Jensen (50 yo)
Mr. Mark Jensen is Chief Executive Officer and President at Ambea AB (publ) since March 2021. He served as Chief Executive Officer of MTR Nordic at MTR Corporation Limited until February 28, 2021. He serve...
CEO Compensation Analysis
Compensation vs Market: Mark's total compensation ($USD993.92K) is about average for companies of similar size in the German market ($USD969.60K).
Compensation vs Earnings: Insufficient data to compare Mark's compensation with company performance.
Experienced Management: 6MA's management team is considered experienced (3.3 years average tenure).
Experienced Board: 6MA's board of directors are considered experienced (5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: 6MA insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Ambea AB (publ)'s employee growth, exchange listings and data sources
- Name: Ambea AB (publ)
- Ticker: 6MA
- Exchange: DB
- Founded: 1996
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: kr4.779b
- Listing Market Cap: kr458.574m
- Shares outstanding: 94.53m
- Website: https://www.ambea.se
Number of Employees
- Ambea AB (publ)
- Evenemangsgatan 21, 6 tr
- Box 1565
- Stockholm County
- 171 29
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/04/25 00:00|
|End of Day Share Price||2022/04/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.